5AM Ventures is back — raising a behemoth of $750 million in two new funds to do what VCs do best.
The life sciences and biotech-focused VC announced the raise earlier this week, closing two funds worth $450 million and $300 million, respectively. Managing Partner Andrew Schwab told Endpoints News that...
